Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00065143. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06599762. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948
ClinicalTrials.gov study NCT05178342. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of SyB C-1101 in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03495167. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biocollection in MyeloDysplastic Syndrome (P-MDS)
ClinicalTrials.gov study NCT04869683. IPD Sharing: YES. Countries: 1. Publications: 0.
Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03184935. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferativ
ClinicalTrials.gov study NCT02795520. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT04550442. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
ClinicalTrials.gov study NCT03397173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04691141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are
ClinicalTrials.gov study NCT04264806. IPD Sharing: YES. Countries: 11. Publications: 0.
Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory
ClinicalTrials.gov study NCT03969446. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01873703. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00956787. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02530463. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
ClinicalTrials.gov study NCT00437450. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01305135. IPD Sharing: NO. Countries: 2. Publications: 0.
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00024050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del
ClinicalTrials.gov study NCT01081431. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02117219. IPD Sharing: Not stated. Countries: 4. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.